Deciphera Pharmaceuticals, Inc. Current Assets
Deciphera Pharmaceuticals, Inc. had Current Assets of $349.94 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2024-05-10
- 2024-03-31: Assets, Current $349.94M.
- 2023-12-31: Assets, Current $381.10M.
- 2023-09-30: Assets, Current $417.58M.
- 2023-06-30: Assets, Current $405.05M.
| Period end | Assets, Current |
|---|---|
| 2024-03-31 | $349.94M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $381.10M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $417.58M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $405.05M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $476.16M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $392.96M 10-K · filed 2024-02-07 |
| 2022-09-30 | $420.88M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $448.53M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $319.83M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $339.01M 10-K · filed 2023-02-07 |
| 2021-09-30 | $385.29M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $437.14M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $546.63M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $584.03M 10-K · filed 2022-02-08 |
| 2020-09-30 | $571.46M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $633.09M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $703.48M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $593.41M 10-K · filed 2021-02-09 |
| 2019-09-30 | $642.29M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $256.43M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $266.44M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $301.04M 10-K · filed 2020-03-09 |
| 2018-09-30 | $325.61M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $348.75M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $181.11M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $198.18M 10-K · filed 2019-03-14 |
| 2016-12-31 | $58.25M 10-K · filed 2018-03-28 |